SPY400.09-1.63 -0.41%
DIA322.78+0.55 0.17%
IXIC11,662.79-142.21 -1.20%

BRIEF-Bioventus Agrees To Nationwide Contract With Cigna Commercial Plans For Durolane And Gelsyn-3

reuters.com · 05/02/2022 07:34
BRIEF-Bioventus Agrees To Nationwide Contract With Cigna Commercial Plans For Durolane And Gelsyn-3

- Bioventus Inc BVS:

  • BIOVENTUS AGREES TO NATIONWIDE CONTRACT WITH CIGNA COMMERCIAL PLANS FOR DUROLANE® AND GELSYN-3® FOR KNEE OSTEOARTHRITIS

  • BIOVENTUS INC - DUROLANE WILL BE EXCLUSIVE TO ALL CIGNA PATIENTS WHILE GELSYN-3 WILL BE ONE OF TWO MULTI-INJECTION HA PRODUCTS UNDER CONTRACT

Source text for Eikon: ID:nGNX6Q0C0z

Further company coverage: BVS


((reuters.briefs@thomsonreuters.com;))